InvestorsHub Logo

centsability4me

04/16/19 8:04 AM

#9763 RE: rrao11 #9762

yes ,
I have a couple items to comment on .

I would have added Sandbox Dental to the DD mix a long time ago
but the Morpheus sleep appliance is in the approval process , and formal operations @ Sandbox have not commenced .

Emvolio Inc. has been dissolved .

Emvolio, Inc. , – was a wholly-owned subsidiary of TSI, incorporated in the State of Delaware on October 3, 2016, for the purpose of filing an Investigation New Drug application with the FDA for our StemVacs immunotherapy vaccine. In May of 2018 President Donald J. Trump signed into the law, the Right To Try bill. Because of this change, Emvolio has decided to withdraw the IND for a Phase 1 trial in the USA because TSI had previously completed a 10 patient trial in Mexico. TSI has since generated GCP documentation for the previously treated 10 patients into a Phase I trial, which will be presented to the FDA by TSI as part of an Ex-US trial compliant with 21 CFR 312.120 Foreign clinical studies not conducted under an IND. Therefore we have dissolved Emvolio, Inc. as it is no longer needed.

That 45 M shares that some thought were the company officers buying up the float, might have been this instead :

On October 25, 2018, we issued 15,000,000 shares of common stock, valued at .0071 each to two officers and one director of the Company under a Restricted Stock Award.

Currently , TSOI is 7.1 M in debt .

that about covers it for me .

Have patience , as the business plan moves forward.
Bio-techs take effort ,time, and money to get where they want to be .